Health Canada
Definition
The federal department that authorises therapeutic products for the Canadian market and issues a Drug Identification Number to each one. Research-use material is not a therapeutic product and carries no DIN, which is the distinction that governs how peptides may be supplied in Canada.
Terms used in this definition
Other entries this definition refers to.
Where this term comes up
Entries whose definition mentions Health Canada.
What this means for research sourcing
Regulatory status varies by jurisdiction and applies to research supply, not human use. Volta sells to researchers only.
Related Terms in Regulatory
MHRA (Medicines and Healthcare products Regulatory Agency)
The United Kingdom regulator for medicines and medical devices. It classifies most therapeutic peptides as prescription-only medicines, a category that governs supply rather than possession.
TGA (Therapeutic Goods Administration)
Australia's regulator for therapeutic goods. It places peptides in scheduling categories, commonly Schedule 4, and sets the rules for importation, which differ from both the US and the EU positions.
NMPA (National Medical Products Administration)
China's medicines regulator. Several metabolic peptides have been approved there on the strength of trials run in Chinese populations, so a compound's approval status is a question about a jurisdiction and not about the molecule.
Jurisdiction
The legal territory whose rules apply, which for peptides decides what may be imported, supplied and prescribed. Approval, scheduling and research-supply rules all vary by jurisdiction, so a single claim about legality is almost always incomplete.
Certificate of Origin
A trade document stating the country where goods were produced, used by customs to apply the correct treatment. It describes provenance and makes no statement about composition, purity or quality.
Boxed Warning
The most serious warning the FDA requires on a product label, set apart in a box. It describes a risk identified for an approved product and is part of the label rather than a statement about a substance in general.
Drug Identification Number (DIN)
The eight-digit number Health Canada assigns to a product authorised for sale in Canada. Its presence means a specific product has been reviewed and authorised; research chemicals carry none.
USP Chapter 797
The United States Pharmacopeia chapter governing compounded sterile preparations, covering environment, training and beyond-use dating. It applies to pharmacies and compounding facilities, not to research supply.